Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Kidney International

• Publication date

  2008-10-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/ki.2008.300PMID 18596730PMCID PMC2586931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 20-Carboxy-arachidonic acid is a dual activator of peroxisome proliferator-activated receptors α and γ

  2007cited by this paper
• 20-carboxy-arachidonic acid is a dual activator of peroxisome proliferator-activated receptors alpha and gamma.

  2007cited by this paper
• Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation.

  2007cited by this paper
• Angiotensin II hypertension is attenuated in interleukin-6 knockout mice.

  2006cited by this paper
• Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues.

  2006cited by this paper
• Induction of Renal 20-Hydroxyeicosatetraenoic Acid by Clofibrate Attenuates High-Fat Diet-Induced Hypertension in Rats

  2006cited by this paper
• Fenofibrate Prevents the Development of Angiotensin II–Dependent Hypertension in Mice

  2005cited by this paper
• Renal epoxyeicosatrienoic acid synthesis during pregnancy.

  2005cited by this paper
• Peroxisome Proliferator-Activated Receptor-&agr; Activation Reduces Salt-Dependent Hypertension During Chronic Endothelin B Receptor Blockade

  2005cited by this paper
• Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.

  2004cited by this paper
• Downregulation of Renal CYP-Derived Eicosanoid Synthesis in Rats With Diet-Induced Hypertension

  2003cited by this paper
• Regulation of cytochrome P-450 4A activity by peroxisome proliferator-activated receptors in the rat kidney.

  2003cited by this paper
• Kidney CYP450 enzymes: biological actions beyond drug metabolism.

  2003cited by this paper
• The CYP4A Isoforms Hydroxylate Epoxyeicosatrienoic Acids to Form High Affinity Peroxisome Proliferator-activated Receptor Ligands*

  2002cited by this paper
• P-450 metabolites of arachidonic acid in the control of cardiovascular function.

  2002cited by this paper
• 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.

  2001cited by this paper
• Increased Expression of Peroxisome Proliferator-Activated Receptor-&agr; and -&ggr; in Blood Vessels of Spontaneously Hypertensive Rats

  2001cited by this paper
• Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats.

  2001cited by this paper
• Intrarenal transport and vasoactive substances in hypertension.

  2001cited by this paper
• Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport.

  2000cited by this paper
• Cytochrome P450-Dependent Renal Arachidonic Acid Metabolism in Desoxycorticosterone Acetate-Salt Hypertensive Mice

  2000cited by this paper
• Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors.

  1999cited by this paper
• Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension.

  1999cited by this paper
• Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors.

  1999cited by this paper
• Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension.

  1999cited by this paper
• Improved separation and immunodetection of rat cytochrome P450 4A forms in liver and kidney.

  1997cited by this paper
• Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans.

  1997cited by this paper
• The cytochrome P450 4 (CYP4) family.

  1997cited by this paper
• 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.

  1997cited by this paper
• Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription.

  1995cited by this paper
• Effect of arachidonic acid on activity of the apical K+ channel in the thick ascending limb of the rat kidney

  1995cited by this paper
• 20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule.

  1995cited by this paper
• Cytochrome P-450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb.

  1994cited by this paper
• Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor.

  1993cited by this paper
• Elevated renovascular tone in young spontaneously hypertensive rats. Role of cytochrome P-450.

  1993cited by this paper
• Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands.

  1993cited by this paper
• Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats.

  1993cited by this paper
• 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries.

  1993cited by this paper
• The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid.

  1992cited by this paper
• Isolation of Preferentially Expressed Genes in the Kidneys of Hypertensive Rats

  1991cited by this paper
• CYP4A subfamily: functional analysis by immunohistochemistry and in situ hybridization.

  1991cited by this paper
• Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle.

  1991cited by this paper
• Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase

  1985cited by this paper
• Control of sodium and potassium transport in the cortical collecting duct of the rat. Effects of bradykinin, vasopressin, and deoxycorticosterone.

  1985cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding

  year unknowncited by this paper

• Salt-sensitive hypertension promotes neuronal mitochondrial stress and neurodegenerative alterations via neuro-vascular metabolic reprogramming and local RAS signaling

  2025cites this paper
• The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction

  2025cites this paper
• Central nervous system mechanisms of salt-sensitive hypertension.

  2025cites this paper
• Aldehyde dehydrogenase 2 attenuates renal injury through inhibiting CYP4A expression.

  2024cites this paper
• Renal medullary overexpression of sphingosine-1-phosphate receptor 1 transgene attenuates deoxycorticosterone acetate (DOCA)-salt hypertension.

  2023cites this paper
• An insight to treat cardiovascular diseases through phytochemicals targeting PPAR-α

  2023cites this paper
• Peroxisome Proliferator-Activated Receptor α Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Angiotensin II-Induced ROS Production

  2022cites this paper
• PPAR-α knockout leads to elevated blood pressure response to angiotensin II infusion associated with an increase in renal α-1 Na+/K+ ATPase protein expression and activity.

  2022cites this paper
• Astaxanthin attenuates cardiovascular dysfunction associated with deoxycorticosterone acetate-salt-induced hypertension in rats

  2022cites this paper
• Collecting duct-specific knockout of sphingosine-1-phosphate receptor 1 aggravates DOCA-salt hypertension in mice

  2021cites this paper
• Antihypertensive potential of selected pyrimidine derivatives: Explanation of underlying mechanistic pathways.

  2021cites this paper
• Role of the Peroxisome Proliferator Activated Receptors in Hypertension

  2021cites this paper
• CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS-induced lipid peroxidation and inflammation

  2020cites this paper
• Fibrates in hypertension: where do we stand?

  2018cites this paper
• Downregulated Serum 14, 15-Epoxyeicosatrienoic Acid Is Associated With Abdominal Aortic Calcification in Patients With Primary Aldosteronism

  2018cites this paper
• Fenofibrate Attenuates Hypertension in Goldblatt Hypertensive Rats: Role of 20‐Hydroxyeicosatetraenoic Acid in the Nonclipped Kidney

  2017cites this paper
• Contribution of PPARα/β/γ, AP-1, importin-α3, and RXRα to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against hypotension, tachycardia, and inflammation in a rat model of septic shock

  2016cites this paper
• Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.

  2016cites this paper
• Cytochrome p450 enzymes in the bioactivation of polyunsaturated Fatty acids and their role in cardiovascular disease.

  2015cites this paper
• Consequences of the loss of the Grainyhead-like 1 gene for renal gene expression, regulation of blood pressure and heart rate in a mouse model.

  2015cites this paper
• Peroxisome proliferator-activated receptors for hypertension.

  2014cites this paper
• 20-HETE and Blood Pressure Regulation: Clinical Implications

  2014cites this paper
• Pharmacological manipulation of arachidonic acid-epoxygenase results in divergent effects on renal damage

  2014influential citation
• Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study

  2014cites this paper
• Alzheimer’s disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs

  2014cites this paper
• Peroxisome proliferator-activated receptors for hypertension World Journal of Cardiology

  2014cites this paper
• Alkaloids of Nitraria sibirica Pall. decrease hypertension and albuminuria in angiotensin II-salt hypertension.

  2014cites this paper
• Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension

  2013cites this paper
• Tissue Distribution and Versatile Functions of PPARs

  2013cites this paper
• 20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases.

  2013cites this paper
• Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension.

  2013cites this paper
• Cytochrome P450 1B1 Gene Disruption Minimizes Deoxycorticosterone Acetate-Salt–Induced Hypertension and Associated Cardiac Dysfunction and Renal Damage in Mice

  2012cites this paper
• Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension , Attenuates Plasma Interleukin-6 Levels and Renal InflammatoryMarkers in Angiotensin II InfusedMice

  2012cites this paper
• Effect of morin, a flavonoid against DOCA-salt hypertensive rats: a dose dependent study.

  2012cites this paper
• Antioxidant SMe1EC2 may attenuate the disbalance of sodium homeostasis in the organism induced by higher intake of cholesterol

  2012cites this paper
• Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.

  2012cites this paper
• Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on adriamycin-induced toxicity of human renal tubular epithelial cell (HK-2).

  2012cites this paper
• Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice

  2012cites this paper
• Antihypertensive and Antioxidant Efficacy of Sesame Cake Extract (SCE) on Uninephrectomized DOCA-Salt Rats.

  2011cites this paper
• Effects of Melothria maderaspatana leaf extract on antioxidant status in sham-operated and uninephrectomized DOCA-salt hypertensive rats.

  2011cites this paper
• Argirein alleviates diabetic nephropathy through attenuating NADPH oxidase, Cx43, and PERK in renal tissue

  2011cites this paper
• Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension

  2011influential citation
• CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice.

  2010cites this paper
• Antihypertensive Efficacy of Melothria maderaspatana leaf extract on shamoperated and uninephrectomized DOCA-salt hypertensive rats

  2010cites this paper
• PPARs: the vasculature, inflammation and hypertension

  2009cites this paper
• Other Transgenic Animal Models Used in Cardiovascular Studies

  2009cites this paper
• Iatrogenic, Congenic, and Transgenic Models of Hypertension

  2009cites this paper